Purchase Order 19PCRD24K5074
- Not listed
- This is a firm fixed-price purchase order awarded by the U.S. Bureau of Administration (a civilian federal agency) to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, for the delivery of medical supplies. The contract has a ceiling value of $12,462.40 and a completion date of June 22, 2024. It is not designated as a set-aside award. The award is associated with Abbott Rapid DX North America LLC's existing federal contract vehicles, including a Blanket Purchase Agreement...
- This is a fixed-price purchase order awarded by the Bureau of Administration, a civilian agency, to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, for the delivery of medical supplies. The contract has a ceiling value of $11,577.60 and a completion date of June 15, 2024. It is not associated with a set-aside program. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic products, including rapid antigen tests, to government agencies such as the...
- This is a $16,875.00 firm-fixed price purchase order contract awarded to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, by the Bureau of Administration, a civilian federal agency. The contract is for the delivery of medical supplies, with a completion date of January 12, 2024. It does not have a set-aside designation. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic products, including rapid antigen tests, to various government agencies,...
- This is a federal contract award to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, to provide medical supplies for the U.S. government. The contract, valued at $10,707.00, is a firm fixed-price purchase order awarded by the Bureau of Administration, a civilian agency. The award has no set-aside designation and has an ultimate completion date of March 20, 2025. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic products, including rapid antigen...
- This is a federal contract award to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, by a civilian federal agency, the Bureau of Administration. The contract is for the provision of medical supplies, specifically COVID-19 diagnostic products including rapid antigen tests, in vitro diagnostics, and molecular testing platforms. The contract is a Firm Fixed Price Purchase Order with a ceiling value of $13,066.00 and an ultimate completion date of June 15, 2024. The contract...
- This is a $12,462.40 firm fixed-price purchase order awarded by the Bureau of Administration, a civilian federal agency, to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The contract is for the delivery of medical supplies and has no set-aside designation. The award is associated with Abbott Rapid DX North America LLC's existing federal contract vehicles, including a Blanket Purchase Agreement with the VA's Veterans Integrated Service Network 1 for medical diagnostic...
- This is a $25,081.00 firm fixed-price purchase order contract awarded by the Bureau of Administration, a civilian federal agency, to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The contract is for the delivery of medical supplies and has a completion date of November 16, 2024. The contract was not set aside for any specific business category. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic equipment, including BinaxNOW rapid antigen tests,...
- This is a $13,866.00 firm fixed-price purchase order awarded by the Bureau of Administration to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The contract is for the delivery of medical supplies, with a period of performance ending on June 27, 2025. This award is not designated as a set-aside contract. The primary contractor, Abbott Rapid DX North America LLC, is a major supplier of COVID-19 diagnostic equipment, including BinaxNOW rapid antigen tests, to various...
- This is a purchase order contract awarded by the Bureau of Administration, a civilian U.S. government agency, to Abbott Rapid DX North America LLC (doing business as Alere North America LLC) for the delivery of laboratory items for various health units. The contract is a firm-fixed-price agreement with a ceiling value of $12,060.60 and a performance period ending on February 17, 2024. Abbott Rapid DX North America LLC is a subsidiary of the larger Abbott Laboratories Inc. company, which has been...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., received a purchase order award from the Bureau of Administration valued at $11,500.00 with a firm fixed price contract type. The award, dated July 31, 2025, has an ultimate completion date of July 31, 2025 and involves part number adjustments. The contract was awarded without a set-aside designation, indicating open competition. The place of performance is located in Lockhart, Florida. Based on Abbott Rapid DX North...
This is a firm fixed-price purchase order contract awarded by the Bureau of Administration, a civilian agency, to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc. The contract, valued at $12,060.60, is for the delivery of medical supplies. The period of performance runs through February 1, 2024. This award does not have a set-aside designation. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic products, including rapid antigen tests, in vitro diagnostics, and molecular diagnostic testing platforms, to various government agencies such as the Department of Veterans Affairs (VA) and Department of Defense (DoD). The company holds several significant federal contract indefinite delivery vehicles, including Blanket Purchase Agreements with VA integrated service networks, to provide medical diagnostic equipment and testing supplies. This particular award supports the agency's ongoing COVID-19 testing and diagnostic needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.1k | 1/3/24 |